Omnicare Inc., a long-term care pharmacy subsidiary of CVS Health Corp., agreed May 16 to pay $8 million to settle a whistle-blower case alleging that its automated systems misrepresented prescription drug information to Medicare and Medicaid (United States ex rel. Corsi, D.N.J., 1:14-cv-01136, settlement 5/16/17).
The agreement, announced May 16 by the U.S. Attorney’s Office for the District of New Jersey, follows a Justice Department investigation into a 2014 whistle-blower complaint brought under the False Claims Act. It’s the latest large monetary settlement to result from interventions by the U.S. and states in whistle-blower cases alleging abuses of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.